Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations

被引:23
作者
Marriott, Christopher
MacRitchie, Helen B.
Zeng, Xian-Ming [1 ]
Martin, Gary P.
机构
[1] Univ Kent, Medway Sch Pharm, Chatham ME4 4TB, Kent, England
[2] Univ Greenwich, Medway Sch Pharm, Chatham ME4 4TB, Kent, England
[3] Kings Coll London, Pharmaceut Sci Res Div, London SE1 9NH, England
关键词
laser diffraction; inertial impaction; salbutamol; dry powder inhaler formulations; fine particle fraction; aerodynamic particle size distribution;
D O I
10.1016/j.ijpharm.2006.07.021
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Impactor data are an essential component of marketing authorisation for new dry powder aerosol formulations. However such data are time-consuming to obtain and therefore impede the rapid screening of pilot formulations. In this phase of development it would be of considerable benefit to employ a technique where data acquisition was more rapid, such as laser diffraction, to predict the fine particle fraction. It was the aim of this study to investigate whether this is a feasible premise. Five different formulations were prepared, each containing 1.5% (w/w) micronised salbutamol base (volume median diameter: 2.42 mu m) blended with the sieved fraction (63-90 mu m) of one of the following sugars: regular crystalline lactose, spray dried lactose "Zeparox (TM)", sorbitol, maltose and dextrose monohydrate. A Perspex (TM) box was constructed to contain particles released from a glass inhaler and allow the particles to be measured by laser diffraction at different flow rates. After being validated using monodisperse aerosols, this assembly was then employed to measure the particle size distributions of each powder formulation and its respective sugar carrier at flow rates ranging from 28.3 to 1001 min(-1). Aerodynamic particle size distribution of salbutamol base from each formulation was also measured after aerosolisation at 28.31 min(-1) from the glass inhaler into an Andersen cascade impactor. The flight of monodisperse particles with diameters (2-6 mu m) in the desired size range of dry powders for inhalation could be contained and the size distribution determined by laser diffraction using the assembly at all flow rates investigated. Treatment of the particle size distributions measured by laser diffraction, i.e. examining only the aerosol particles with diameter < 60 mu m, highlighted the fine fraction (< 5 mu m) and enabled the aerosolisation of different blends to be feasibly compared at a range of different flow rates. The blends containing the following excipients could be placed in the following order of increasing fine fraction: spray-dried lactose < dextrose << maltose < lactose < sorbitol. At 28.31 min(-1) a significant linear correlation was found between the fine fractions measured by laser diffraction and the salbutamol fine fractions determined by inertial impaction (R-2 = 87.4%, p = 0.02, ANOVA). Therefore, the laser diffraction technique could prove to be an important tool for particle size characterisation of dry powder aerosol formulations. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:39 / 49
页数:11
相关论文
共 20 条
[1]   An analysis of the Fraunhofer Diffraction method for particle size distribution analysis and its application to aerosolized sprays [J].
Annapragada, A ;
Adjei, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 127 (02) :219-227
[2]   Influence of excipients and storage humidity on the deposition of disodium cromoglycate (DSCG) in the Twin Impinger [J].
Braun, MA ;
Oschmann, R ;
Schmidt, PC .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 135 (1-2) :53-62
[3]  
Chawla A., 1993, Journal of Pharmacy and Pharmacology, V45, P1148
[4]   THE USE OF LASER DIFFRACTION FOR THE EVALUATION OF THE AEROSOL CLOUDS GENERATED BY MEDICAL NEBULIZERS [J].
CLARK, AR .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 115 (01) :69-78
[5]   Design and application of a new modular adapter for laser diffraction characterization of inhalation aerosols [J].
de Boer, AH ;
Gjaltema, D ;
Hagedoorn, P ;
Schaller, M ;
Witt, W ;
Frijlink, HW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 249 (1-2) :233-245
[6]   Characterization of inhalation aerosols: a critical evaluation of cascade impactor analysis and laser diffraction technique [J].
de Boer, AH ;
Gjaltema, D ;
Hagedoorn, P ;
Frijlink, HW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 249 (1-2) :219-231
[7]   AN ALTERNATIVE AEROSOL DELIVERY SYSTEM FOR AMILORIDE [J].
EVERARD, ML ;
DEVADASON, SG ;
SUNDERLAND, VB ;
LESOUEF, PN .
THORAX, 1995, 50 (05) :517-519
[8]   CHARACTERIZATION OF A CONDENSATION-TYPE MONODISPERSE AEROSOL GENERATOR (MAGE) [J].
HORTON, KD ;
MILLER, RD ;
MITCHELL, JP .
JOURNAL OF AEROSOL SCIENCE, 1991, 22 (03) :347-363
[9]  
Moreno J D, 1998, J Health Care Law Policy, V1, P1
[10]   Evolution of dry powder inhaler design, formulation, and performance [J].
Newman, SP ;
Busse, WW .
RESPIRATORY MEDICINE, 2002, 96 (05) :293-304